drugset / Trial / NCT04684238

Effect & Safety of Inhaled Isoflurane vs IV Midazolam for Sedation in Mechanically Ventilated Children 3-17 Years Old

NCT04684238 ↗

Phase 3 Completed 94 enrolled Sedana Medical
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a study to compare safety and efficacy of inhaled isoflurane delivered by the AnaConDa-S (Anaesthetic Conserving Device (ACD)) versus intravenous midazolam for sedation in mechanically ventilated children admitted to an intensive care unit.

Timeline

Start
2021-01-14
Primary completion
2023-01-19
Completion
2023-01-19

Outcome

Mixed primary results

paper The least-squares mean difference between treatments was 6·57 percentage points (95% CI -8·99 to 22·13), indicating non-inferiority PMID 40680761 ↗

paper non-inferiority (margin -9·36 percentage points) PMID 40680761 ↗

registry Least square means 5.34 (95% CI -10.48 to 21.17); note: Testing the hypothesis of no difference between isoflurane and midazolam. NCT04684238 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Isoflurane Other / unclassified — Inhaled
Comparator Midazolam Small molecule — Intravenous

Indications

No indication recorded.